40
total announcements
QUICKHEAL.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹828 Cr
EPS (TTM)
₹-2.15
52W Low
₹125.00
52W High
₹371.40
Dividend Yield
0.00%
Beta
0.26
Price / Book
1.9
Debt / Equity
0.0
Revenue (TTM)
₹249 Cr
Gross Margin
98.34%
Operating Margin
-47.61%
Quick Heal Technologies Limited
Quick Heal Technologies Limited has informed the Exchange regarding 'Intimation of 31st Annual General Meeting' to be held on September 23, 2026, through Video Conferencing / Other Audio Visual Means.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has informed the Exchange regarding the grant of 102000 Employee Stock Options (Options) to employees under ESOP Scheme 2021, in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has informed the Exchange about the resignation of a Director/KMP/SMP, but no further details are provided.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has appointed Mr. Rajiv Sreekantan as Senior Vice President - Enterprise Sales, effective August 11, 2026.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has informed the Exchange regarding the resignation of Mr. Samuel Sathyajith as Senior Vice President - Enterprise Sales of the company on or before September 04, 2026.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has informed the Exchange regarding 'Machine Readable Financial Results' for the quarter ended June 30, 2026. The company has approved unaudited consolidated and standalone financial results, issued a Limited Review Report with an unmodified opinion, and proposed the re-appointment of Mr. Richard Stiennon as Non-Executive Independent Director.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has informed the Exchange about the resignation of a Director/KMP/SMP.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has informed the Exchange regarding Cessation of Dr. Lalit Mohan Sanagavarapu as Other of the company w.e.f. August 07, 2026.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has informed the Exchange about Copy of Newspaper Publication regarding the outcome of the Board Meeting.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue of ₹45.0 Cr, EBITDA of ₹-17.6 Cr, and PAT of ₹-5.3 Cr. The company has also announced the re-appointment of Mr. Richard Stiennon as Non-Executive Independent Director for a second term of 5 consecutive years. Additionally, the company has shifted its Registered Office within the same city limit and updated its books of accounts.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has appointed Richard Stiennon as a Non-Executive Independent Director for a second term of 5 consecutive years, subject to shareholder approval.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue of ₹45.0 Cr, EBITDA of ₹-17.6 Cr, and PAT of ₹-5.3 Cr.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has informed the Exchange regarding the allotment of 5,332 shares under the ESOP Scheme 2021.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has filed a certificate under SEBI (Depositories and Participants) Regulations, 2018.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has informed the Exchange regarding the allotment of 10,286 shares under the ESOP Scheme 2021. The shares will be credited to the permanent ISIN of the company upon final trading approval.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has submitted a disclosure to the NSE under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This filing confirms the company's adherence to regulatory requirements concerning changes in shareholding or control. Regulation 31(4) typically relates to promoters or persons in control modifying or revoking undertakings not to encumber shares. While this announcement does not detail the specifics of Quick Heal's disclosure, such submissions are crucial for maintaining transparency around potential shifts in ownership structure. Investors should monitor subsequent announcements for the full context and any implications for the company's control.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has granted 220,000 employee stock options to employees under the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has appointed Mr. Harish Kumar GS as its Chief Executive Officer, effective June 18, 2026.
Quick Heal Technologies Limited
Quick Heal Technologies Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 18, 2026, where the Board approved the appointment of Mr. Harish Kumar GS as Chief Executive Officer and Key Managerial Personnel.